Related references
Note: Only part of the references are listed.PML in a person with multiple sclerosis: Is teriflunomide the felon?
Lorena Lorefice et al.
NEUROLOGY (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned (vol 17, pg 467, 2018)
E. O. Major et al.
LANCET NEUROLOGY (2018)
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients
Elizabeth A. Mills et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients
Elizabeth A. Mills et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
Eugene O. Major et al.
LANCET NEUROLOGY (2018)
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
Thomas Berger et al.
CNS DRUGS (2017)
Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
David Baker et al.
JAMA NEUROLOGY (2017)
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity
Onajite Kousin-Ezewu et al.
NEUROLOGY (2014)
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab
Morten Blinkenberg et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
Immune competence after alemtuzumab treatment of multiple sclerosis
Claire L. McCarthy et al.
NEUROLOGY (2013)
Impairment of JCV-specific T-cell response by corticotherapy
Caroline Antoniol et al.
NEUROLOGY (2012)
Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient
Alessandra Sottini et al.
PLOS ONE (2012)
Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation
Alessandra Sottini et al.
CLINICAL IMMUNOLOGY (2010)
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
Yanping Hu et al.
IMMUNOLOGY (2009)
Determination of thymic function direct from peripheral blood: A validated modification to an established method
A. R. Lorenzi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion
Menno C. van Zelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Quantitation of DNA of polyomaviruses BK and JC in human kidneys
P Randhawa et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
DC Douek et al.
LANCET (2000)
Share Paper
